US Stock MarketDetailed Quotes

Brainstorm Cell Therapeutics (BCLI)

Watchlist
  • 0.8649
  • -0.0019-0.21%
15min DelayClose Apr 14 14:34 ET
9.54MMarket Cap-0.78P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Brainstorm Cell Therapeutics (BCLI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.88%9.95M
-29.63%2.24M
-32.84%2.05M
-13.72%2.57M
24.86%3.09M
-45.46%11.69M
-33.62%3.19M
-49.49%3.05M
-45.27%2.98M
-51.97%2.47M
Selling and administrative expenses
-17.95%5.78M
-5.05%1.39M
-42.69%1.15M
-29.47%1.45M
17.98%1.79M
-34.14%7.04M
-52.80%1.47M
-25.95%2M
-22.41%2.06M
-32.06%1.51M
-General and administrative expense
-17.95%5.78M
-5.05%1.39M
-42.69%1.15M
-29.47%1.45M
17.98%1.79M
-34.14%7.04M
-52.80%1.47M
-25.95%2M
-22.41%2.06M
-32.06%1.51M
Research and development costs
-10.23%4.18M
-50.55%852K
-13.97%899K
21.48%1.12M
35.69%1.3M
-56.72%4.65M
1.47%1.72M
-68.62%1.05M
-67.00%922K
-67.13%961K
Operating profit
14.88%-9.95M
29.63%-2.24M
32.84%-2.05M
13.72%-2.57M
-24.86%-3.09M
45.46%-11.69M
33.62%-3.19M
49.49%-3.05M
45.27%-2.98M
51.97%-2.47M
Net non-operating interest income expense
-592.21%-533K
-187.88%-190K
-9.26%-59K
-1,200.00%-330K
253.85%46K
82.77%-77K
87.73%-66K
55.37%-54K
-75.00%30K
-85.87%13K
Non-operating interest income
----
----
----
----
253.85%46K
----
----
----
-75.00%30K
-85.87%13K
Total other finance cost
592.21%533K
187.88%190K
9.26%59K
1,200.00%330K
----
-82.77%77K
-87.73%66K
-55.37%54K
---30K
----
Other net income (expense)
21.77%179K
0
119.04%179K
-96.87%147K
219.49%282K
-92.01%394K
411K
-940K
Gain on sale of security
21.77%179K
--0
----
----
119.04%179K
-96.87%147K
219.49%282K
-92.01%394K
--411K
---940K
Income before tax
11.32%-10.31M
18.13%-2.43M
22.23%-2.11M
-14.25%-2.9M
15.79%-2.86M
32.39%-11.62M
46.70%-2.97M
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
Income tax
Net income
11.32%-10.31M
18.13%-2.43M
22.23%-2.11M
-14.25%-2.9M
15.79%-2.86M
32.39%-11.62M
46.70%-2.97M
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
Net income continuous Operations
11.32%-10.31M
18.13%-2.43M
22.23%-2.11M
-14.25%-2.9M
15.79%-2.86M
32.39%-11.62M
46.70%-2.97M
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
Minority interest income
Net income attributable to the parent company
11.32%-10.31M
18.13%-2.43M
22.23%-2.11M
-14.25%-2.9M
15.79%-2.86M
32.39%-11.62M
46.70%-2.97M
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.32%-10.31M
18.13%-2.43M
22.23%-2.11M
-14.25%-2.9M
15.79%-2.86M
32.39%-11.62M
46.70%-2.97M
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
Basic earnings per share
51.95%-1.11
60.78%-0.2
62.75%-0.19
43.33%-0.34
40.00%-0.45
61.50%-2.31
69.09%-0.51
-13.33%-0.51
69.23%-0.6
64.29%-0.75
Diluted earnings per share
51.95%-1.11
60.78%-0.2
62.75%-0.19
43.33%-0.34
40.00%-0.45
61.50%-2.31
69.09%-0.51
-13.33%-0.51
69.23%-0.6
64.29%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -14.88%9.95M-29.63%2.24M-32.84%2.05M-13.72%2.57M24.86%3.09M-45.46%11.69M-33.62%3.19M-49.49%3.05M-45.27%2.98M-51.97%2.47M
Selling and administrative expenses -17.95%5.78M-5.05%1.39M-42.69%1.15M-29.47%1.45M17.98%1.79M-34.14%7.04M-52.80%1.47M-25.95%2M-22.41%2.06M-32.06%1.51M
-General and administrative expense -17.95%5.78M-5.05%1.39M-42.69%1.15M-29.47%1.45M17.98%1.79M-34.14%7.04M-52.80%1.47M-25.95%2M-22.41%2.06M-32.06%1.51M
Research and development costs -10.23%4.18M-50.55%852K-13.97%899K21.48%1.12M35.69%1.3M-56.72%4.65M1.47%1.72M-68.62%1.05M-67.00%922K-67.13%961K
Operating profit 14.88%-9.95M29.63%-2.24M32.84%-2.05M13.72%-2.57M-24.86%-3.09M45.46%-11.69M33.62%-3.19M49.49%-3.05M45.27%-2.98M51.97%-2.47M
Net non-operating interest income expense -592.21%-533K-187.88%-190K-9.26%-59K-1,200.00%-330K253.85%46K82.77%-77K87.73%-66K55.37%-54K-75.00%30K-85.87%13K
Non-operating interest income ----------------253.85%46K-------------75.00%30K-85.87%13K
Total other finance cost 592.21%533K187.88%190K9.26%59K1,200.00%330K-----82.77%77K-87.73%66K-55.37%54K---30K----
Other net income (expense) 21.77%179K0119.04%179K-96.87%147K219.49%282K-92.01%394K411K-940K
Gain on sale of security 21.77%179K--0--------119.04%179K-96.87%147K219.49%282K-92.01%394K--411K---940K
Income before tax 11.32%-10.31M18.13%-2.43M22.23%-2.11M-14.25%-2.9M15.79%-2.86M32.39%-11.62M46.70%-2.97M-120.88%-2.71M52.32%-2.54M32.77%-3.4M
Income tax
Net income 11.32%-10.31M18.13%-2.43M22.23%-2.11M-14.25%-2.9M15.79%-2.86M32.39%-11.62M46.70%-2.97M-120.88%-2.71M52.32%-2.54M32.77%-3.4M
Net income continuous Operations 11.32%-10.31M18.13%-2.43M22.23%-2.11M-14.25%-2.9M15.79%-2.86M32.39%-11.62M46.70%-2.97M-120.88%-2.71M52.32%-2.54M32.77%-3.4M
Minority interest income
Net income attributable to the parent company 11.32%-10.31M18.13%-2.43M22.23%-2.11M-14.25%-2.9M15.79%-2.86M32.39%-11.62M46.70%-2.97M-120.88%-2.71M52.32%-2.54M32.77%-3.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.32%-10.31M18.13%-2.43M22.23%-2.11M-14.25%-2.9M15.79%-2.86M32.39%-11.62M46.70%-2.97M-120.88%-2.71M52.32%-2.54M32.77%-3.4M
Basic earnings per share 51.95%-1.1160.78%-0.262.75%-0.1943.33%-0.3440.00%-0.4561.50%-2.3169.09%-0.51-13.33%-0.5169.23%-0.664.29%-0.75
Diluted earnings per share 51.95%-1.1160.78%-0.262.75%-0.1943.33%-0.3440.00%-0.4561.50%-2.3169.09%-0.51-13.33%-0.5169.23%-0.664.29%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -